We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

InPractice Survey on the Treatment of Hypercholesterolemia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00523796
First Posted: September 3, 2007
Last Update Posted: February 16, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
August 30, 2007
September 3, 2007
February 16, 2011
February 2007
November 2007   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00523796 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
InPractice Survey on the Treatment of Hypercholesterolemia
InPractice Survey on the Treatment of Hypercholesterolemia
This is a multi-centre survey of patients who are currently on lipid-lowering pharmacological treatment. Data collection for each patient will take place at one visit.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
primary care
Hypercholesterolemia
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
2500
November 2007
November 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subject must be 18 years of age or older of either sex.
  • Subject is on lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.

Exclusion Criteria:

  • Subjects who are unwilling or unable to provide informed consent.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Vietnam
 
 
NCT00523796
NIS-CVN-CRE-2007/1
VN-NIS-0001 ( Other Identifier: NIS Registry )
No
Not Provided
Not Provided
Not Provided
AstraZeneca
Not Provided
Study Chair: Pham Gia Khai, Prof Vietnamese Cardiovascular Association
Study Chair: Nguyen Manh Phan, Prof Vietnamese Cardiovascular Association
Study Director: Than Trong Son, MD AstraZeneca
AstraZeneca
February 2011